Dramatic Increase in prevalence of fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain

Journal of Clinical Microbiology

Volumn 42, Issue 10, 2004, Pages 4769-4775

  Valverde, Aránzazu ^a   Coque, Teresa M ^a   Sánchez Moreno, M Paz ^b   Rollán, Azucena ^a   Baquero, Fernando ^a   Cantón, Rafael ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b Laboratorio Municipal de Higiene   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; QUINOLONE; STREPTOMYCIN; SULFONAMIDE; TETRACYCLINE; TRIMETHOPRIM;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM COLONY; BACTERIUM ISOLATE; CHILD; CLONE; CONTROLLED STUDY; ENTEROBACTERIACEAE; ENZYME ASSAY; ENZYME SYNTHESIS; EPIDEMIC; ESCHERICHIA COLI; FECES ANALYSIS; FECES CULTURE; FEMALE; GENE SEQUENCE; GENETIC VARIABILITY; HOSPITAL PATIENT; HUMAN; ISOELECTRIC FOCUSING; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; OUTPATIENT; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SPAIN; SPECIES ENDEMICITY;

BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; ELECTROPHORESIS, GEL, PULSED-FIELD; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FECES; HOSPITALIZATION; HUMANS; MICROBIAL SENSITIVITY TESTS; PREVALENCE; SPAIN; TIME FACTORS;

BACTERIA (MICROORGANISMS); ENTEROBACTERIACEAE; ESCHERICHIA COLI; NEGIBACTERIA;

EID: 5444248381     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.42.10.4769-4775.2004     Document Type: Article

References (47)

1. Arduino, S. M., M. Catalane, B. E. Orman, P. H. Roy, and D. Centron. 2003. Molecular epidemiology of orf513-bearing class 1 integrons in multiresistant clinical isolates from Argentinean hospitals. Antimicrob. Agents Chemother. 47:3945-3949.
2. Asensio, A., A. Oliver, P. Gonzalez-Diego, F. Baquero, J. C. Pérez-Diμaz, P. Ros, J. Cobo, M. Palacios, D. Lasheras, and R. Canton. 2000. Outbreak of a multiresistant Klebsiella pneumoniae strain in an intensive care unit: antibiotic use as risk factor for colonization and infection. Clin. Infect. Dis. 30:55-60.
3. Baquero, F., T. M. Coque, and R. Cantón. 2002. Allodemics. Lancet Infect. Dis. 2:591-592.
4. Bonnet, R. 2004. Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob. Agents Chemother. 48:1-14.
5. Bonomo, R. A., C. J. Donskey, J. L. Blumen, A. M. Hujer, C. K. Hoyenm, M. R. Jacobs, C. C. Whalen, and R. A. Salata. 2003. Cefotaxime-resistant bacteria colonizing older people admitted to an acute care hospital. J. Am. Geriatr. Soc. 51:519-522.
6. Bonten, M. J., S. Slaughter, A. W. Ambergen, M. K. Hayden, J. van Voorhis, C. Nathan, and R. A. Weinstein. 1998. The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch. Intern. Med. 158:1127-1132.
7. Bradford, P. A. 2001. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14:933-951.
8. Briñas, L., M. A. Moreno, M. Zarazaga, C. Porrero, Y. Saenz, M. García, L. Domínguez, and C. Torres. 2003. Detection of CMY-2, CTX-M-14, and SHV-12 β-lactamases in Escherichia coli fecal-sample isolates from healthy chickens. Antimicrob. Agents Chemother. 47:2056-2058.
9. Briñas, L., M. Zarazaga, Y. Saenz, F. Ruiz-Larrea, and C. Torres. 2002. β-Lactamases in ampicillin-resistant Escherichia coli isolates from foods, humans, and healthy animals. Antimicrob. Agents Chemother. 46:3156-3163.
10. Cantón, R., T. M. Coque, and F. Baquero. 2003. Multi-resistant gram-negative bacilli: from epidemics to endemics. Curr. Opin. Infect. Dis. 16:315-325.
11. Coque, T. M., A. Oliver, J. C. Perez-Diaz, F. Baquero, and R. Cantón. 2002. Genes encoding TEM-4, SHV-2, and CTX-M-10 extended-spectrum β-lactamases are carried by multiple Klebsiella pneumoniae clones in a single hospital (Madrid, 1989 to 2000). Antimicrob. Agents Chemother. 46:500-510.
12. De Champs, C., M. P. Sauvant, C. Chanal, D. Sirot, N. Gazuy, R. Malhuret, J. C. Baguet, and J. Sirot. 1989. Prospective survey of colonization and infection caused by expanded-spectrum-β-lactamase-producing members of the family Enterobactenaceae in an intensive care unit. J. Clin. Microbiol. 27:2887-2890.
13. Essack, S. Y., L. M. Hall, D. G. Pillay, M. L. McFadyen, and D. M. Livermore. 2001. Complexity and diversity of Klebsiella pneumoniae strains with extended-spectrum β-lactamases isolated in 1994 and 1996 at a teaching hospital in Durban, South Africa. Antimicrob. Agents Chemother. 45:88-95.
14. Gniadkowski, M. 2001. Evolution and epidemiology of extended-spectrum β-lactamases (ESBLs) and ESBL-producing microorganisms. Clin. Microbiol. Infect. 7:597-608.
15. Green, M., and K. Barbadora. 1998. Recovery of ceftazidime-resistant Klebsiella pneumoniae from pediatric liver and intestinal transplant recipients. Pediatr. Transplant. 2:224-230.
16. Harris, A. D., L. Nemoy, J. A. Johnson, A. Martin-Carnahan, D. L. Smith, H. Standiford, and E. N. Perencevich. 2004. Co-carriage rates of vancomycin-resistant Enterococcus and extended-spectrum beta-lactamase-producing bacteria among a cohort of intensive care unit patients: implications for an active surveillance program. Infect. Control Hosp. Epidemiol. 25:105-108.
17. Hollander, R., M. Ebke, H. Barck, and E. von Pritzbuer. 2001. Asymptomatic carriage of Klebsiella pneumoniae producing extended-spectrum β-lactamase by patients in a neurological early rehabilitation unit: management of an outbreak. J. Hosp. Infect. 48:207-213.
18. Huovinen, S. 1988. Rapid isoelectric focusing of plasmid-mediated β-lactamases with Pharmacia PhastSystem. Antimicrob. Agents Chemother. 32:1730-1732.
19. Jarlier, V., M. Nicolas, G. Fournier, and A. Philippen. 1988. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev. Infect. Dis. 10:867-878.
20. Jutersek, B., A. Baraniak, T. Zohar-Cretnik, A. Storman, E. Sadowy, and M. Gniadkowski. 2003. Complex endemic situation regarding extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a hospital in Slovenia. Microb. Drug Resist. 9(Suppl. 1):S25-S33.
21. Kaufmann, M. E. 1998. Pulsed-field-electrophoresis, p. 33-50. In N. Woodford and A. P. Johnson (ed.), Molecular bacteriology. Protocols and clinical applications. Humana Press, Totowa, N.J.
22. Levin, B. R. 2001. Minimizing potential resistance: a population dynamics view. Clin. Infect. Dis. 33(Suppl. 3):S161-S169.
23. Lipsitch, M., and M. H. Samore. 2002. Antimicrobial use and antimicrobial resistance: a population perspective. Emerg. Infect. Dis. 8:347-354.
24. Livermore, D. M. 1995. β-Lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 8:557-584.
25. Mabilat, C., and S. Goussard. 1995. PCR detection and identification of genes for extended-spectrum β-lactamases, p. 553-557. In D. H. Persing, T. F. Smith, F. C. Tenover, and T. J. White (ed.), Diagnostic molecular microbiology: principles and applications. American Society for Microbiology, Washington, D.C.
26. Mazzariol, A., J. Zuliani, R. Fontana, and G. Cornagua. 2003. Isolation from blood culture of a Ledercia adecarboxylata strain producing an SHV-12 extended-spectrum β-lactamase. J. Clin. Microbiol. 41:1738-1739.
27. Medeiros, A. A. 1997. Evolution and dissemination of β-lactamases accelerated by generations of β-lactam antibiotics. Clin. Infect. Dis. 24(Suppl. 1):S19-S45.
28. Millar, M. R., T. R. Walsh, C. J. Linton, S. Zhang, J. P. Leeming, P. M. Bennett, et al. 2001. Avon Longitudinal Study of Pregnancy and Childhood. Carriage of antibiotic-resistant bacteria by healthy children. J. Antimicrob. Chemother. 47:605-610.
29. Mirellis, B., F. Navarro, E. Miró, R. J. Mesa, P. Coll, and G. Prats. 2003. Community transmission of extended-spectrum β-lactamase. Emerg. Infect. Dis. 9:1024-1025.
30. Moland, E. S., J. A. Black, A. Hossain, N. D. Hanson, K. S. Thomson, and S. Pottumarthy. 2003. Discovery of CTX-M-like extended-spectrum beta-lactamases in Escherichia coli isolates from five U.S. states. Antimicrob. Agents Chemother. 47:2382-2383.
31. National Committee for Clinical Laboratory Standards. 2003. Performance standards for antimicrobial disk susceptibility tests. NCCLS document M2-A8. Approved standard, 8th ed. National Committee for Clinical Laboratory Standards, Wayne, Pa.
32. National Committee for Clinical Laboratory Standards. 2003. MIC methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. NCCLS document M7-A6. Approved standard, 6th ed. National Committee for Clinical Laboratory Standards, Wayne, Pa.
33. Oliver, A., L. M. Weigel, J. K. Rasheed, J. E. McGowan Juniorperiod, P. Raney, and F. C. Tenover. 2002. Mechanisms of decreased susceptibility to cefpodoxime in Escherichia coli. Antimicrob. Agents Chemother. 46:3829-3836.
34. Oliver, A., J. C. Pérez-Díaz, T. M. Coque, F. Baquero, and R. Cantón. 2001. Nucleotide sequence and characterization of a novel cefotaxime-hydrolyzing β-lactamase (CTX-M-10) isolated in Spain. Antimicrob. Agents Chemother. 45:616-620.
35. Osterblad, M., A. Hakanen, R. Manninen, T. Leistevuo, R. Peltonen, O. Meurman, P. Huovinen, and P. Kotilainen. 2000. A between-species comparison of antimicrobial resistance in enterobacteria in fecal flora. Antimicrob. Agents Chemother. 44:1479-1484.
36. Paterson, D. L., K, M. Hujer, A. M. Hujer, B. Yeiser, M. D. Bonomo, L. B. Rice, R. A. Bonomo, and the International Klebsiella Study Group. 2003. Extended-spectrum β-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV-and CTX-M-type β-lactamases. Antimicrob. Agents Chemother. 47:3554-3560.
37. Paterson, D. L., L. Muiazimoglu, J. M. Casellas, W. C. Ko, H. Goossens, A. Von Gottberg, S. Mohapatra, G. M. Trenholme, K. P. Klugman, J. G. McCormack, and V. L. Yu. 2000. Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumonias isolates causing bacteremia. Clin. Infect. Dis. 30:473-478.
38. Peña, C., M. Pujol, C. Ardanuy, A. Ricart, R. Pallares, J. Linares, J. Ariza, and F. Gudiol. 1998. Epidemiology and successful control of a large outbreak due to Klebsiella pneumonias producing extended-spectrum β-lactamases. Antimicrob. Agents Chemother. 42:53-58.
39. Rodríguez-Baño, J., M. D. Navarro, L. Romero, L. Martínez-Martínez, M. A. Muniain, E. J. Perea, R. Pérez-Cano, and A. Pascual. 2004. Epidemiology and clinical features of infections caused by extended-spectrum β-lactamase-producing Escherichia coli in nonhospitalized patients. J. Clin. Microbiol. 42:1089-1094.
40. Singh, N., K. M. Patel, M. M. Leger, B. Short, B. M. Sprague, N. Kalu, and J. M. Campos. 2002. Risk of resistant infections with Enterobacteriaceae in hospitalized neonates. Pediatr. Infect. Dis. J. 21:1029-1033.
41. Smith, D. L., J. Dushoff, E. N. Perencevich, A. D. Harris, and S. A. Levin. 2004. Persistent colonization and the spread of antibiotic resistance in nosocomial pathogens: resistance is a regional problem. Proc. Natl. Acad. Sci. USA 101:3709-3714.
42. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
43. Tolun, V., O. Kucukbasmaci, D. Torumkuney-Akbulut, C. Catal, M. Ang-Kucuker, and O. Ang. 2004. Relationship between ciprofloxacin resistance and extended-spectrum β-lactamase production in Escherichia coli and Klebsiella pneumoniae strains. Clin. Microbiol. Infect. 10:72-75.
44. Trick, W. E., R. A. Weinstein, P. L. DeMarais, M. J. Kuehnert, W. Tomaska, C. Nathan, T. W. Rice, S. K. McAllister, L. A. Carson, and W. R. Jarvis. 2001. Colonization of skilled-care facility residents with antimicrobial-resistant pathogens. J. Am. Geriatr. Soc. 49:270-276.
45. Wiener, J., J. P. Quinn, P. A. Bradford, R. V. Goering, C. Nathan, K. Bush, and R. A. Weinstein. 1999. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 281:517-523.
46. Winokur, P. L., R. Canton, J. M. Casellas, and N. Legakis. 2001. Variations in the prevalence of strains expressing an extended-spectrum β-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin. Infect. Dis. 32(Suppl. 2):S94-S103.
47. Xiong, Z., D. Zhu, F. Wang, Y. Zhang, R. Okamoto, and M. Inoue. 2002. Investigation of extended-spectrum beta-lactamase in Klebsiellae pneumoniae and Escherichia coli from China. Diagn. Microbiol. Infect. Dis. 44:195-200.